子中子捕获疗法在瘤异质性的背景下:进展,挑战和未来的前景
Rongmiao Zhou1, Zhun You1, Liang Liu1
1Cancer Institute, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in oncology
|November 3, 2025
概括
中子捕获疗法 (BNCT) 通过向瘤,同时节省健康组织来治疗各种癌症,显示出希望. 克服输送剂和中子源的挑战是推动这种创新的癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 辐射疗法 辐射疗法
背景情况:
- 中子捕获疗法 (BNCT) 是一种新兴的二元治疗方法,利用的核性质来向瘤破坏.
- 传递剂和基于加速器的中子源的进步正在促进临床应用.
- BNCT已在头癌,质瘤和黑色素瘤中表现出有效性,其他瘤类型的研究正在进行中.
研究的目的:
- 在过去十年中,提供中子捕获疗法 (BNCT) 的全面审查.
- 检查作用机制,临床研究环境和影响BNCT疗效的因素.
- 确定BNCT开发和临床翻译的关键挑战和未来方向.
主要方法:
- 过去十年BNCT研究的系统文献综合.
- 对治疗机制,临床试验结果和治疗疗效标志物的分析.
- 确定输送剂,中子源,瘤异质性和临床转化方面的挑战.
主要成果:
- BNCT在治疗特定癌症方面表现出有效性,在头部和部癌症方面获得临床批准.
- 在开发具有改进性质的输送剂方面取得了进展.
- 在提高BNCT疗效方面仍然存在重大挑战,包括药剂开发,中子源技术和临床标准化.
结论:
- BNCT是一种有前途的癌症治疗,在临床上取得了成功,特别是在头癌中.
- 克服传递剂,中子源和临床翻译方面的挑战对于更广泛的BNCT应用至关重要.
- 涉及技术创新,政策支持和跨学科合作的综合方法对于推动BNCT至关重要.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


